Variability in uptake efficiency for pulsed versus constant concentration delivery of inhaled nitric oxide by Andrew R Martin et al.
MEDICAL GAS 
RESEARCH
Martin et al. Medical Gas Research 2014, 4:1
http://www.medicalgasresearch.com/content/4/1/1RESEARCH Open AccessVariability in uptake efficiency for pulsed versus
constant concentration delivery of inhaled nitric
oxide
Andrew R Martin1,4, Chris Jackson1,5, Ira M Katz2,3* and Georges Caillibotte2Abstract
Background: Nitric oxide (NO) is currently administered using devices that maintain constant inspired NO
concentrations. Alternatively, devices that deliver a pulse of NO during the early phase of inspiration may have use
in optimizing NO dosing efficiency and in extending application of NO to long-term use by ambulatory,
spontaneously breathing patients. The extent to which the amount of NO delivered for a given pulse sequence
determines alveolar concentrations and uptake, and the extent to which this relationship varies with breathing
pattern, physiological, and pathophysiological parameters, warrants investigation.
Methods: A mathematical model was used to analyze inhaled nitric oxide (NO) transport through the conducting
airways, and to predict uptake from the alveolar region of the lung. Pulsed delivery was compared with delivery of
a constant concentration of NO in the inhaled gas.
Results: Pulsed delivery was predicted to offer significant improvement in uptake efficiency compared with constant
concentration delivery. Uptake from the alveolar region depended on pulse timing, tidal volume, respiratory
rate, lung and dead space volume, and the diffusing capacity of the lung for NO (DLNO). It was predicted
that variation in uptake efficiency with breathing pattern can be limited using a pulse time of less than
100 ms, with a delay of less than 50 ms between the onset of inhalation and pulse delivery. Nonlinear variation in
uptake efficiency with DLNO was predicted, with uptake efficiency falling off sharply as DLNO decreased below ~
50-60 ml/min/mm Hg. Gas mixing in the conducting airways played an important role in determining uptake, such
that consideration of bulk convection alone would lead to errors in assessing efficiency of pulsed delivery systems.
Conclusions: Pulsed NO delivery improves uptake efficiency compared with constant concentration delivery.
Optimization of pulse timing is critical in limiting intra- and inter-subject variability in dosing.
Keywords: Lung model, Trumpet model, Medical gas, Nitric oxide, Gas transport, Conducting airways, Mixing,
Dispersion, Bolus, PulseBackground
Inhaled nitric oxide (NO) has been shown to act as a se-
lective pulmonary vasodilator [1,2]. Since this discovery
more than 20 years ago, use of NO has become widespread
for treating persistent pulmonary hypertension of the new-
born (PPHN) [3], improving oxygenation in adult patients
with acute lung injury or the acute respiratory distress syn-
drome [4], and in alleviating pulmonary hypertension in* Correspondence: ira.katz@airliquide.com
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stated.adults and children following cardiac surgery [5,6]. These
settings generally require NO to be delivered to mechani-
cally ventilated patients. To do so, delivery devices have
been developed which administer NO from a source cylin-
der containing 100–1000 ppm NO (800 ppm NO in North
America) in balance nitrogen, to the inspiratory limb of the
patient breathing circuit. The flow rate of NO injection is
adjusted in proportion to the flow of air/oxygen in the cir-
cuit so as to produce a constant NO concentration in the
inspired gas [7,8]. Accordingly, dosing recommendations
for inhaled NO have been established based on the NO
concentration in inspired gas [4,9].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Conducting airway dimensions from Finlay et al.
[16]
GEN# Diameter (cm) Length (cm) Volume* (ml)
0 1.80 12.46 32.05
1 1.41 3.61 11.35
2 1.12 2.86 11.17
3 0.89 2.28 11.22
4 0.71 1.78 11.13
5 0.57 1.13 9.03
6 0.45 0.90 9.29
7 0.36 0.83 11.00
8 0.29 0.75 12.22
9 0.22 0.65 12.46
10 0.16 0.56 11.79
11 0.12 0.45 10.67
12 0.09 0.36 9.74
13 0.07 0.28 9.53
14 0.06 0.22 10.49
*Total volume of 2n airways in generation n.
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dose–response relationship for inhaled NO might be
better described in terms of alveolar concentration or
uptake from the lungs, rather than inhaled concentration
[10,11]. Such considerations have often been made in
the context of pulsed NO delivery systems, which deliver
a predetermined volume of NO in the early portion of
inhalation, with the goal of maximizing delivery to the
peripheral, gas exchange lung regions, while avoiding de-
livery of NO to the anatomical dead space near the end
of inhalation [11-15]. Pulsed systems may have use in
optimizing dosing and minimizing total NO usage for
intubated, ventilated patients, but also in extending ap-
plication of NO to long-term use by ambulatory, spon-
taneously breathing patients. However, these systems are
inherently poorly described using the established dose
metric of inhaled NO concentration, as the concentra-
tion is intentionally varied over each inhalation. Instead,
they are potentially well adapted for dosing in terms of
the absolute amount (volume, mass, moles) of NO deli-
vered per breath or over a given time period. The extent
to which the amount of NO delivered for a given pulse
sequence determines alveolar concentrations and up-
take, and the extent to which this relationship varies
with breathing pattern, and with physiological and
pathophysiological parameters, is presently unclear,
and thus warrants study.
This article describes a mathematical model developed
to couple gas mixing and transport through the con-
ducting airways with uptake from the alveolar lung
region. Continuous or pulsed NO delivered to the extra-
thoracic airway was transported through serial airway
generations by a combination of bulk convection and
axial dispersion. Uptake from the alveolar region was de-
termined as a function of alveolar volume and NO con-
centration, as well as the diffusing capacity of the lung
for NO. The model was used to evaluate equivalency, in
terms of alveolar concentration and uptake, between
constant concentration and pulsed NO dosing, and to
establish framework recommendations on pulse volume,
duration, and delay time (between onset of inhalation
and pulse delivery) for optimal uptake efficiency. In
addition, the significance of axial dispersion on NO
transport, and ultimately uptake, was evaluated, as was




A single compartment, single path lung model was
employed. The lung was divided into a gas-conducting
region and an alveolar region. It was assumed that zero
uptake of NO occurred across the conducting airways,
whereas uptake from the alveolar region into thecapillaries was modeled with a single transfer factor
specifying volume uptake per unit time per unit partial
pressure (i.e., DLNO – the diffusing capacity of the
lung for NO). Inputs to the model included the DLNO,
along with the functional residual capacity (FRC) of
the lung, the dimensions of the conducting airways,
the breathing pattern (inhaled and exhaled volumetric
flow rates vs. time), and the variation in inhaled NO
concentration specified over time. Outputs of the
model included the time-varying concentrations of NO
in each generation of the conducting airways and in
the alveolar region, the rate at which NO was taken up
into the capillaries, and the NO concentration in the
exhaled gas.
Conducting airways
The tracheobronchial airways making up the gas-
conducting region of the lung can be described as a
symmetric, bifurcating network of rigid, cylindrical tubes
starting at the trachea and extending to the terminal
bronchioles. In the present work, baseline dimensions of
the conducting airways were specified according to the
adult model provided by Finlay et al. [16], based on air-
way data from Phillips et al. [17]. These are provided in
Table 1, and correspond to a FRC of the lung of
3000 ml. Airway lengths and diameters were then scaled
with FRC according to




Figure 1 Ratio between the two components of the effective
diffusion coefficient during inhalation and exhalation over the
conducting airways.
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represents the corresponding length or diameter at FRC
of 3000 ml.
Proximal to the trachea, an extrathoracic airway was
defined by a characteristic diameter and length of
0.75 cm and 30 cm, respectively, to represent an adult
endotracheal tube.
Dispersion of inhaled NO through the extrathoracic
and conducting airways was analyzed following an ap-
proach analogous to the Eulerian dynamical framework
outlined by Finlay [18] for modeling aerosol transport
through the respiratory tract. In brief, the convection-
diffusion equation was solved in one dimension over a
single path, with the coordinate x representing the depth
into the lung along that path. The conducting airway di-
mensions described above were used to define the total
cross-sectional area of airways in the lung as a function
of x. It was assumed that the flux of NO through airway
walls was zero, and that conducting airway cross-
sections remained constant over time. The 1D transport
equation could then be written in differential form as
∂
∂t
Acð Þ þ ∂
∂x







where A is the total cross-sectional area of airways in
the lung at a given depth x, c is the NO concentration
averaged over the area A, u is the average flow velocity
in the x-direction over the area A, and Dm is the mo-
lecular diffusivity of NO in air.
Equation (2) assumes both the velocity and the NO
concentration are uniform across the area A. In general,
these variables are not uniform, and their variation
across the entire airway cross section at a given lung
depth is complex. To preserve the simplicity of the 1D
model, a common approach is to replace Dm with an ef-
fective diffusion coefficient Deff, the latter acting as a
catch-all term encompassing both molecular diffusion
and various convective-diffusive dispersion phenomena
arising from non-uniform velocity and concentration
profiles. The effective diffusion coefficient can thus be
written as the summation
Deff ¼ Dm þ Dc−d ð3Þ
where Dc-d represents the contribution of convective-
diffusive dispersion to the total effective diffusive flux.
Ben-Jebria [19] presented compelling arguments that
flow patterns through the conducting airways are suffi-
ciently complex that gas mixing cannot be described
using the laminar dispersion model described by Taylor
[20], but should instead be estimated based on experi-
ments performed by Scherer et al. [21] on gas dispersion
in a physical model of the first five branches of theconducting airways. In the latter approach, the disper-
sion coefficient is
Dc−d ¼ αud ð4Þ
where α is an empirical constant equal to 1.08 during
inhalation and 0.37 during exhalation, and d is the diameter
of the airway.
Using equation (4), Dc-d may be calculated and
compared to Dm for each generation of the conduc-
ting airways. This was done for airway velocities ū
corresponding to a 300 ml/s inspiratory flow rate and
500 ml/s expiratory flow rate using airway diameters
specified in the Finlay et al. [16] airway model de-
scribed above, and using a molecular diffusivity of
NO in air of 0.23 cm2/s. The comparison is presented
in Figure 1, where it can be seen that Dc-d is much
greater than Dm during both inhalation and exha-
lation through most of the conducting airways, but
that molecular diffusivity becomes non-negligible in
the small airways approaching the transition to the
alveolar region.















For each case studied, the time variation of NO
concentration was specified at the entrance to the
extrathoracic airway, the concentration gradients at
the entrance and at the boundary between conducting
airways and the alveolar region were set to zero, and
the initial
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geometry. That is










c x; t ¼ 0ð Þ ¼ 0
ð6Þ
where f(t) specifies the inhaled NO concentration over
time, and x = L denotes the boundary between conduct-
ing airways and alveolar region.
Alveolar region
The alveolar region was modeled as a single, well-mixed
compartment that expanded and contracted during the
breathing cycle consistent with the inhaled and exhaled
tidal volume. The mass conservation of NO in the alveo-
lar region during inhalation can be written as
d calvV alvð Þ
dt
¼ c14Q−calvDLNO ð7Þ
and during exhalation as






¼ Q tð Þ ð9Þ
and where Q is the instantaneous volumetric flow rate of
gas into or out of the lungs,Valv is the volume of the al-
veolar region, calv and c14 represent the NO concentra-
tions in the alveolar region and in the terminal
bronchioles (generation 14), respectively, and DLNO is
the diffusing capacity of the lung for NO. DLNO is
normally specified as the volume uptake of NO per
unit time per unit partial pressure, but as written in
equations (7) and (8) DLNO must be expressed in units
of the quantity of NO conserved (i.e., mass, moles, or
volume at STP) per unit time per unit concentration.
After expanding the left hand sides of equations (7)
and (8) using the product rule, and rearranging terms,
the rate of change of alveolar concentration of NO was












Equation (5) was discretized and solved through the
extrathoracic and conducting airways over finite divi-
sions of length using an upwind approximation for the
convective term and a central difference approximation
for the diffusive term. The discretized transport equation
during inhalation was







Ai−1 þ Aið Þ Def f ti−1 þ Def f ti
  Ct−Δti−1 −Ct−Δti
li−1 þ li
 







and during exhalation was







Ai−1 þ Aið Þ Def f ti−1 þ Def f ti
  Ct−Δti−1 −Ct−Δti
li−1 þ li
 
− Ai þ Aiþ1ð Þ Def f ti þ Def f tiþ1







t is the NO concentration in the ith division at
time t, and li is the length of the i
th division. The param-
eters uti and Deff,i
t were known, and prescribed at the
start of the procedure based on the specified breathing
pattern and airway dimensions.
Alveolar concentrations were calculated directly using
the finite difference versions of equations (10) and (11)
during inhalation and exhalation, respectively.
Concentrations throughout the respiratory tract were
calculated explicitly over time via the Euler method. To
assess time step and spatial grid size dependence, initial
calculations were performed with 1000, 2500, 5000, or
10000 equal time steps per breath, and for 1, 2, 3, or 5
equal length divisions per generation. For constant in-
haled NO concentrations, increasing the number of time
steps per breath or divisions per generation had negli-
gible effect on NO uptake and uptake efficiency, save
that in the case of 5 divisions per generation 5000 time
steps per breath were required for convergence. For cal-
culations performed for pulsed NO delivery, increasing
the number of divisions per generation from 1 to 3 re-
duced NO uptake and uptake efficiency slightly, while
further increase above 3 divisions had negligible effect.
Effects of time step size were negligible, save that again
5000 time steps per breath were required for conver-
gence in the case of 5 divisions per generation. For all
combinations of time step and divisions, convergence
or divergence of the solution was well predicted by
Martin et al. Medical Gas Research 2014, 4:1 Page 5 of 13
http://www.medicalgasresearch.com/content/4/1/1applying the practical criterion given by Darquenne
and Paiva [22] at the terminal conducting airway (gene-
ration 14 in the present model). Results presented
below were obtained using 5 divisions per generation
and 5000 time steps per breath.
Cases studied
The model presented above was first verified through
comparison with a model previously proposed by
Heinonen et al. [11], which compared well with in vivo
exhaled NO concentrations measured by the same au-
thors during continuous and pulsed delivery of NO to
intubated, mechanically ventilated pigs. For the purpose
of comparison, all parameters were set equal to those re-
ported by Heinonen et al. [11]. The idealized flow pat-
tern described in Figure 2 was adopted, with tidal
volume of 400 ml, respiratory rate of 20 min-1, inspira-
tory time fraction equal to 1/3 of the breath, and the ex-
piratory time constant equal to 0.37 s. In addition, the
DLNO was set to 48 ml/min/mm Hg, FRC to 700 ml,
and airway dimensions were scaled to yield an anato-
mical dead volume of 150 ml. Following Heinonen et al.
[11], the NO concentration in inhaled gas was either set
to a constant 5 ppm throughout inhalation, or, for the
case of pulsed delivery of 100 nmol NO/min, a 110 μl
pulse containing 1000 ppm NO in balance nitrogen was
injected during only the first third of each inhalation at
a flow rate of 0.33 ml/s. In the latter case, the NO/N2
stream was assumed to be well mixed with the inhaled
air stream at the entrance to the extrathoracic region.
Alveolar NO concentrations (FANO), NO uptake effi-
ciency (defined as the mass of NO absorbed from theFigure 2 Idealized breathing pattern (top) and pulse form (bottom) ualveolar region divided by the mass of NO inhaled), and
exhaled NO concentrations (FENO) were compared
between the present model and that proposed by
Heinonen et al. [11]. In addition, model predictions were
compared with exhaled peak and end-tidal NO concen-
trations measured in pigs by Heinonen et al. [11] for the
cases of constant 5 ppm NO delivery, and pulsed deli-
very of 100 nmol NO/min.
Subsequent calculations were performed using the
present model to simulate constant and pulsed delivery
of NO to adult humans. A base parameter set was de-
fined with FRC of 3000 ml, DLNO of 150 ml/min/mm Hg,
tidal volume of 500 ml, breath frequency of 12 min-1, in-
spiratory time fraction of 1/3, and expiratory time constant
of 0.6 s. Individual parameters were varied to explore their
effects on NO uptake and uptake efficiency. The breathing
pattern took the form shown in Figure 2, with constant in-
halation flow and an exponentially-decaying exhalation
flow. The coefficient A defining the peak expiratory flow
was calculated for a given inhaled tidal volume, expiratory
time constant, and expiratory time so as to set the exhaled
tidal volume equal to the inhaled tidal volume.
Proportional delivery was modeled using a constant
20 ppm inhaled concentration of NO. Three different pulse
durations, tpulse, were studied: 100, 200, and 400 ms. Pulses
were modeled as square waves as depicted in Figure 2. Each
pulse delivered 8 μg NO/breath (equivalent to 267 nmol
NO/breath). This dose was chosen based on initial calcula-
tions performed using the model so as to yield equivalent
alveolar NO concentration and uptake for the base param-
eter set as the constant 20 ppm delivery case. For tpulse of
100, 200, and 400 ms, 800 ppm NO in balance N2 wassed as inputs to the model.
Martin et al. Medical Gas Research 2014, 4:1 Page 6 of 13
http://www.medicalgasresearch.com/content/4/1/1introduced at 75, 37.5 and 18.75 mL/s, respectively. Again,
the NO/N2 stream was assumed to be well mixed with
the inhaled air stream at the entrance to the extra-
thoracic region. The effect of delay between the start of
inspiration and pulse delivery was studied by setting a pulse
delay, tpulse delay, of 0, 50, 100, 200 ms.
Results
Model verification
Table 2 lists peak and end tidal values of the alveolar
NO concentration, FANO, and exhaled NO concentra-
tion, FENO, predicted using the present model and the
model presented by Heinonen et al. [11], as well as aver-
age peak and end tidal values of FENO from experiments
in intubated, mechanically ventilated pigs presented by
the same authors. NO uptake efficiency as determined
by the two models is also presented. In general, very
close agreement was seen between the two models.
Constant concentration versus pulsed dosing
Figure 3 displays variation of NO concentration over
time and location from delivery through the segmental
bronchi (generation 3), and in the alveolar region, for
constant 20 ppm delivery, and for delivery of a 100 ms
pulse containing 800 ppm NO at 75 ml/s into the inhal-
ation flow, with zero pulse delay. Concentrations for both
delivery modes are presented for the base parameter set.
Figure 4 shows alveolar concentrations at a more appropri-
ate concentration scale, for both the constant 20 ppm
delivery, and for the three pulse delivery cases, again for the
base parameter set. The pulse volumes were set so as to
achieve very similar alveolar concentrations as for the con-
stant 20 ppm case.
Variation in NO uptake and NO uptake efficiency
with breathing and physiological parameters is shown
in Figures 5 and 6, respectively. All plots in Figure 5Table 2 Comparison of nitric oxide concentrations and uptak
FANO, peak FANO, end tida
Delivery mode [ppb] [ppb]
Present model:
5 ppm constant 1066 216
100 nmol/min pulsed 100 17
Heinonen et al. [11] model:
5 ppm constant 1250 250
100 nmol/min pulsed 125 25
Heinonen et al. [11] data*:
5 ppm constant — —
100 nmol/min pulsed — —
*As reported in Heinonen et al. [11] based on experimental regression values.
FANO = Alveolar fraction of NO.
FENO = Exhaled fraction of NO.
Uptake Efficiency = (NO uptake)/(NO inhaled).include a point of intersection between the pulsed and
constant delivery modes, consistent with the choice of
pulse volume to yield equivalent alveolar NO concentra-
tion as constant 20 ppm delivery for the base parameter
set. No points of intersection between modes exist in
Figure 6, where in all cases the NO uptake efficiency is
significantly lower for constant than for pulsed delivery.
Effects of pulse delay
Uptake efficiency is provided is Table 3 for varying time
delays between the start of inhalation and delivery of the
NO pulse. Data is provided for the base parameter set,
with tidal volume (Vt) of 500 ml and breathing fre-
quency (f ) of 12 min-1, as well as for three other combi-
nations with Vt = 250 ml and/or f = 25 min
-1. All other
parameters were held constant at values defined for the
base parameter set. While uptake efficiency remained
above 0.9 for all combinations of pulse time and delay
for Vt = 500 ml and f = 12 min
-1, efficiency decreased dra-
matically with pulse time and delay for the case of rapid,
shallow breathing with Vt = 250 ml and f = 25 min
-1.
Uptake efficiency versus DLNO
Figure 7 plots variation in uptake efficiency with DLNO for
constant delivery of 20 ppm NO and for the 100 ms pulsed
delivery, for two breathing patterns. In all cases studied,
uptake efficiency was relatively constant for DLNO larger
than ~80 ml/min/mm Hg, increasing by less than 0.1 as
DLNO increased up to 200 ml/min/mm Hg. However,
uptake efficiency became more sensitive to DLNO at values
less than ~80 ml/min/mm Hg, and began to drop off
sharply as DLNO fell below ~50-60 ml/min/mm Hg.
Discussion
Uptake of NO from the alveolar region depended on
pulse timing, tidal volume, respiratory rate, lung ande efficiencies in intubated, mechanically ventilated pigs








Figure 3 Regional variation of NO concentration over time. Shown for (a) delivery of a constant 20 ppm concentration during inhalation and
(b) delivery of a 100 ms pulse containing 800 ppm NO at 75 ml/s into the inhalation flow, sequenced with the start of each inhalation with zero
pulse delay. Note the difference in concentration scales between the two plots. Alveolar concentrations are displayed on a more appropriate
scale in Figure 4.
Figure 4 Alveolar NO concentration (FANO) versus time for the first 7 breaths after starting constant or pulsed NO delivery. Pulsed
dosing was sequenced with the start of each inhalation with zero pulse delay.
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Figure 5 Total NO uptake over a 60 seconds time period for pulsed and constant concentration delivery. Plotted with varying (a) tidal
volume, (b) inspiratory time fraction, (c) breathing frequency, (d) functional residual capacity (FRC), (e) expiratory time constant, and (f) varying
FRC together with tidal volume, where tidal volume is scaled in proportion to FRC. When not the varied parameter, the following values were
used: FRC = 3000 ml, DLNO = 150 ml/min/mm Hg, tidal volume = 500 ml, breath frequency = 12 min
-1, inspiratory time fraction = 1/3, and
expiratory time constant = 0.6 s.
Martin et al. Medical Gas Research 2014, 4:1 Page 8 of 13
http://www.medicalgasresearch.com/content/4/1/1dead space volume, and the diffusing capacity of the
lung for NO (DLNO). In general, uptake efficiency was
consistently higher for pulsed NO delivery than for con-
stant concentration delivery. As will be discussed below,
pulse time and delay influenced uptake efficiency more
significantly as breath frequency increased, and as tidal
volume decreased. In these circumstances, gas mixing in
the conducting airways played an important role in de-
termining uptake efficiency for pulsed delivery.
Model verification
In order to verify calculations made using the model
presented above, predictions of alveolar and exhaled NO
concentrations, and NO uptake efficiency, were com-
pared with those made previously by Heinonen et al.
[11]. Those authors constructed a model simulating bulk
convection through a single channel, representing theconducting airways, supplying an elastic compartment,
representing the alveolar region, and found good agree-
ment with peak and end-tidal exhaled NO concentration
measured during pulsed and constant concentration NO
delivery to intubated, mechanically ventilated pigs. As
seen in Table 2, predictions made using the present
model were in close agreement with those made by
Heinonen et al. [11]. The agreement between these
two distinct models, and their consistency with in vivo
data from an animal model, provides a measure of con-
fidence in moving forward to make predictions regar-
ding NO delivery to humans.
Constant concentration versus pulsed dosing
One practical application of the model presented here is
to guide the design of pulsed NO dosing systems. A lo-
gical starting point is to tune pulse volume and timing
Figure 6 NO uptake efficiency for pulsed and constant concentration delivery. Plotted with varying (a) tidal volume, (b) inspiratory time
fraction, (c) breathing frequency, (d) functional residual capacity (FRC), (e) expiratory time constant, and (f) varying FRC together with tidal
volume, where tidal volume is scaled in proportion to FRC. When not the varied parameter, the following values were used: FRC = 3000 ml,
DLNO = 150 ml/min/mm Hg, tidal volume = 500 ml, breath frequency = 12 min
-1, inspiratory time fraction = 1/3, and expiratory time
constant = 0.6 s.
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uptake as predicted for delivery of a given constant NO
concentration, where dose–response relationships are
more established. This was the approach adopted in
selecting the 8 μg NO/breath pulses studied herein. As
shown in Figure 4, for the base set of input parameters,
variation in alveolar concentration over time is very
similar for the three pulsed delivery modes as for con-
stant delivery of 20 ppm inhaled NO. NO uptake was
also nearly identical between the pulsed and constant
modes. Each input parameter was then varied independ-
ently to assess its influence on NO uptake, and results
are presented in Figure 5. The same calculations are pre-
sented in terms of uptake efficiency in Figure 6. With
the exception of respiratory rate, variation of NO uptake
is predicted to be less influenced by input parameter
variation for pulsed than for constant dosing. In particu-
lar, NO uptake for pulsed delivery is predicted to berelatively insensitive to tidal volume and FRC, except
when tidal volume becomes small or FRC large, in which
cases uptake is seen to decrease. Noting that conducting
airway volume scaled with FRC, the latter effect arises due
to incomplete transport of NO through the conducting air-
ways during inhalation, such that an increasing fraction of
NO is exhaled. When tidal volume was allowed to increase
in proportion with FRC, as in Figures 5f and 6f, NO uptake
and uptake efficiency remained constant for pulsed dosing
as FRC varied.
Of note, uptake efficiency was predicted to remain sig-
nificantly greater for pulsed dosing than for constant
dosing in all cases presented in Figure 6. This is seen as
an advantage of pulsed delivery systems, in that less NO
may be required to maintain an equivalent therapeutic
effect. A potential further advantage of pulsed dosing
systems is to improve correlation between NO dose and
patient response. Under the assumption that therapeutic
Table 3 Effects of pulse time and pulse delay on nitric oxide uptake efficiency for varied breathing patterns
Uptake efficiency
Pulse Pulse Vt = 500 ml Vt = 500 ml Vt = 250 ml Vt = 250 ml
Time [ms] Delay [ms] f = 12 min-1 f = 25 min-1 f = 12 min-1 f = 25 min-1
100 0 0.94 0.89 0.88 0.81
50 0.94 0.89 0.85 0.72
100 0.94 0.89 0.81 0.59
200 0.94 0.88 0.70 0.24
200 0 0.94 0.89 0.84 0.70
50 0.94 0.89 0.80 0.57
100 0.94 0.88 0.76 0.42
200 0.94 0.86 0.63 0.14
400 0 0.94 0.88 0.74 0.42
50 0.94 0.86 0.68 0.31
100 0.94 0.81 0.61 0.22
200 0.93 0.62 0.46 0.07
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would ideally remain near 1.0, or at least remain con-
stant, such that the rate of NO uptake could be closely
estimated based on the rate of NO delivery. This would
allow dosing to be performed through monitoring the
absolute amount (mass, volume, moles) of NO delivered,
with the potential to improve dose–response corre-
lations [10,11].
Effects of pulse delay
While uptake efficiency remained near 1.0 for the majo-
rity of the parameter range presented in Figure 6, the
case of low tidal volume was further examined, as re-
ported in Table 3. Here, the delay time between onset of
inhalation and pulse delivery was also considered. At a
resting breathing pattern with tidal volume of 500 ml
and breathing frequency of 12 min-1, uptake efficiencyFigure 7 NO uptake efficiency is plotted against DLNO for pulsed and
FRC was held constant at 3000 ml, as was inspiratory time fraction at 1/3.remained above 0.9 even for the extreme case of a
400 ms pulse, with 200 ms delay. In contrast, for rapid,
shallow breathing with tidal volume of 250 ml and
breathing frequency of 25 min-1, uptake efficiency was
lower, and much more sensitive to both pulse time and
delay. In order to minimize these effects, a pulse time of
100 ms or less, with delay less than 50 ms, is desirable.
Making a comparison with pulsed oxygen delivery de-
vices, as have previously been adapted for ambulatory
NO delivery through nasal cannulae [12,13], a 50 ms
delay is within the range of values reported for commer-
cially available devices [23]. In turn, a pulse time of
100 ms is near reported values for the lowest pulse set-
ting on the majority of devices [23]. Given that required
pulse volumes for high concentration NO source gas will
generally be smaller than for oxygen, pulse times at or
below 100 ms are technically feasible.constant concentration delivery for two breathing patterns.
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All results discussed above were obtained from calcula-
tions in which the DLNO was fixed at 150 ml/min/mm
Hg. This falls approximately in the middle of the range
reported by Zavorsky et al. [24] for healthy adults per-
forming single-breath-hold maneuvers at rest. Significant
variation between subjects is expected even in healthy
populations, and certainly in patients with respiratory or
cardiovascular disease. For example, in patients with pul-
monary arterial hypertension (PAH), average DLNO values
have been reported as approximately 60–80 ml/min/mm
Hg [25,26], with values below 50 ml/min/mm Hg reported
in individual patients [25]. Figure 7 demonstrates consider-
able sensitivity of uptake efficiency to DLNO within lower
ranges, especially for pulsed delivery. In contrast, at higher
ranges, uptake efficiency was much less sensitive to DLNO,
indicative of excess capacity to take up NO at typical thera-
peutic dose levels in lungs which maintain normal, or near-
normal, alveolar membrane conductance. It is interesting
to comment that even for the most efficient case studied,
100 ms pulse with zero delay, uptake efficiency is predicted
to lie between approximately 0.7 and 0.9 for DLNO values
typical of PAH patients. This presents an apparent discrep-
ancy with clinical experience delivering pulsed NO to PAH
patients, where no detectable exhaled NO has been re-
ported [13,15], suggesting an uptake efficiency near 1.0. It
may be that exhaled NO concentrations in clinical evalua-
tions were simply below the detection limit of the analyzers
employed (peak exhaled NO would likely not exceed 1 or
2 ppm, and last fractions of a second, while end-tidal values
would lie well below 1 ppm).
Based on present understanding, it appears that the
amount of NO delivered is not directly predictive of the
amount of NO uptake, such that monitoring NO deli-
very alone cannot be considered a substitute for moni-
toring uptake. As variation in uptake efficiency is moreFigure 8 Uptake efficiency for pulsed delivery from Table 3 is plotted
space volume (VD,anat). The flush volume is defined as the tidal volume mpronounced at low DLNO, considerable dose titration
may be required for patients with initially low DLNO
that receive NO therapy. This is true for both pulsed
dosing and constant concentration dosing. In relative
terms, pulsed dosing offered considerable improvement
in uptake efficiency compared with constant concen-
tration dosing even for the lowest DLNO values studied.Nitrogen dioxide production
It may be noted that reaction between NO and oxygen
to produce nitrogen dioxide (NO2) has not been in-
cluded in the present model description. In fact, a ver-
sion of the model was built to include such effects, but
NO2 production was extremely small. This can be de-
duced from back of the envelope calculations, given that
the chemical kinetics and rate of reaction between NO
and oxygen are well known [27]. For example, at a rep-
resentative inhalation flow rate of 300 ml/s, the resi-
dence time of gases passing through the conducting
airways is less than 1 s. For 20 ppm NO reacting with
100% oxygen, less than 10 parts per billion (ppb) NO2
are produced per second. While initial NO concentra-
tions are higher for pulsed delivery, dispersion is rapid
(Figure 3b) such that these higher concentrations are
very short lived. In the alveolar region, NO concentra-
tions are much lower: assuming an alveolar NO concen-
tration maintained at 1 ppm through supply from the
conducting airways, the time to produce 1 ppm NO2,
even in 100% oxygen, is more than 10 hours – and this
assumes NO2 accumulates in the alveolar region with no
uptake. While such conditions may be possible during
extended NO delivery to patients with poorly ventilated
and poorly perfused lung regions, the risk of NO2 pro-
duction in the lungs is small in comparison with the risk
of NO2 developing in breathing circuits used to conveyagainst the ratio between flush volume (Vf) and anatomical dead
inus the total volume inhaled during the delay time and pulse time.
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of sufficiently large NO concentrations and residence
times to produce appreciable amounts of NO2 may exist,
and precautions to avoid excess NO2 production have
been documented [10,28].
Conducting airways model
The present model treated the conducting airways as
a series of individual generations, and included axial
dispersion of NO through the empirical coefficient pro-
posed by Scherer et al. [21]. One may reasonably question
whether modelling axial dispersion provides any significant
insight in comparison with simpler models. In describing
pulsed oxygen delivery, other investigators have used ideal-
ized bulk analysis based on relative volumes of the conduc-
ting airways (anatomical dead space) and tidal breath
[29,30]. With regards to the present work, Figure 8 high-
lights the significance of including mixing in the conduct-
ing airways as opposed to a bulk analysis based on relative
airway and tidal volumes. The ‘flush volume’, Vf, is defined
as the tidal volume minus the total volume inhaled during
the delay time and pulse time. Under a volumes-based ana-
lysis, so long as the flush volume is greater than the volume
of the anatomical dead space, all NO delivered in the pulse
is swept into the alveolar region, and made available for up-
take. In contrast, Figure 8 displays uptake efficiency as low
as 0.7 in the region of the plot where flush volume exceeds
dead space volume, indicating that a portion of NO re-
mains in the conducting airways at the end of inhalation
(this was confirmed by viewing generational concentration
data). Accordingly, gas mixing in the conducting airways
plays an important role in determining the efficiency of
pulsed delivery systems.
Limitations
Several limitations of the present model present opportu-
nities for future work. First, extension to multiple paths and
multiple compartments would allow the interplay between
regional variation of respiratory mechanics, ventilation, per-
fusion, and uptake efficiency to be explored. Second, the
possibility of significant concentration gradients within the
alveolar air spaces could be explored by moving to a multi-
generation model of the alveolar region [31,32], with poten-
tial impact on total uptake efficiency. Finally, the present
model treated the extrathoracic airway as a single tube, rep-
resentative of an endotracheal tube, while pulsed delivery
has frequently been linked with long term administration of
NO through nasal cannulae. Depending on the cannula de-
sign, mixing of NO source gas with room air, and with any
additional supplemental oxygen, will occur during transit
through the nasal air passages and will determine boundary
conditions entering the trachea. More accurate repre-
sentation of concentration profiles exiting the extra-
thoracic airway will likely require bench experiments,or computational fluid dynamics simulations, specific
to a given patient interface and nasal airway geometry.
Conclusions
In conclusion, pulsed NO delivery offers significant im-
provement in uptake efficiency compared with constant
concentration delivery. However, uptake from the alveo-
lar region can depend on pulse timing, tidal volume, re-
spiratory rate, lung and dead space volume, and DLNO.
It is predicted that variation in uptake efficiency with
breathing pattern can be moderated using a pulse time
of less than 100 ms, with a delay of less than 50 ms
between the onset of inhalation and pulse delivery.
Nonlinear variation in uptake efficiency with DLNO was
predicted, with uptake efficiency falling off sharply as
DLNO decreased below ~50-60 ml/min/mm Hg. Gas
mixing in the conducting airways played an important
role in determining uptake efficiency for pulsed delivery.
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